MetaADEDB 2.0 @ LMMD
atosiban
(VWXRQYYUEIYXCZ-OBIMUBPZSA-N)
Structure
SMILES
NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C
Type(s)
Approved; Investigational
ATC code(s)
G02CX01
Molecular Formula:
C43H67N11O12S2
Molecular Weight:
994.189
Log P:
1.4200
Hydrogen Bond Acceptor:
25
Hydrogen Bond Donor:
11
TPSA:
416.27
CAS Number(s):
90779-69-4
Synonym(s)
1.
atosiban
2.
(Mpa(1),D-Tyr(Et)2,Thr(4),Orn(8))oxytocin
3.
(Mpa(1)-D-Tyr(Et)(2)-Thr(4)-Orn(8))-oxytocin
4.
1-deamino-2-Tyr(OEt)-4-Thr-8-Orn-oxytocin
5.
ORF 22164
6.
ORF-22164
7.
RWJ 22164
8.
RWJ-22164
9.
oxytocin, 1-deamino-(O-Et-Tyr)(2)-Thr(4)-Orn(8)-
10.
oxytocin, 1-deamino-O-ethyltyrosyl(2)-threonyl(4)-ornithine(8)-
External Link(s)
MeSHC047046
PubChem Compound5311010
BindingDB50177595
ChEBI135899
CHEMBLCHEMBL382301
DrugBankDB09059
DrugCentral3008
IUPHAR/BPS Guide to PHARMACOLOGY2213
KEGGdr:D03008
Therapeutic Target DatabaseD0D8XY
ZINC169362009
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DermatitisSIDER
2DizzinessSIDER
3HeadacheSIDER
4HypersensitivitySIDER
5Hypotension19696681CTD
SIDER
6Injection Site ReactionSIDER
7MalnutritionSIDER
8Multiple PregnancySIDER
9NauseaSIDER
10PruritusSIDER
11Seizures27220266CTD
12TachycardiaSIDER
13VomitingSIDER
14nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.